Search - tctmd.com

Displaying 881 - 900 of 1498

Sort: Relevancy | Date

Presentation TVT 2019

Comparison of 3D Transesophageal Echocardiogram vs. CTA for TAVR Valve Sizing and Resulting Aortic Regurgitation

Presenter: Sarfaraz Memon

June 14, 2019

Presentation TVT 2019

Diastolic Dysfunction and Clinical Outcomes in Non-Typical Aortic Stenosis Subtypes After Transcatheter Aortic Valve Replacement

Presenter: Rashad Belin

June 14, 2019

Presentation TVT 2019

Renin-Angiotensin-Aldosterone System Inhibitors Are Associated With Reno-Protective Effects in Aging Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Alexis Okoh

June 14, 2019

Presentation TVT 2019

Utilizing a Protocol-Driven vs. a Guideline-Driven Approach for Management of Conduction Abnormalities After Transcatheter Aortic Valve Replacement

Presenter: Chad Kliger

June 14, 2019

Presentation TVT 2019

Does Orienting Sapien 3 During Crimping in TAVR Affect Final Orientation to Coronaries to Impact TAV-in-TAV and Coronary Reaccess? A Pilot Study

Presenter: Gilbert Tang

June 14, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Technology Description and Clinical Data

Presenter: Mathew Williams

June 13, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

Presentation TVT 2019

Technology Description, Clinical Data and Plans for the US Pivotal Trial

Presenter: Martin Leon

June 13, 2019

Presentation TVT 2019

Which Patients Should Still Have Surgical AVR? Who Are Poor Candidates for TAVR?

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

Presenter: John Webb

June 13, 2019

Presentation TVT 2019

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Presenter: Martin Leon

June 13, 2019

Presentation TVT 2019

Does Surgical Risk Still Matter When Evaluating for TAVR?

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2019

The LOTUS Edge TAVR System: Clinical Trial Updates

Presenter: Chris Meduri

June 13, 2019

Presentation TVT 2019

Design Characteristics, Clinical Data, and Future Vision

Presenter: Alexandre Abizaid

June 13, 2019

Presentation TVT 2019

Design Characteristics, Clinical Data, and Future Vision

Presenter: Gregory Fontana

June 13, 2019

Presentation TVT 2019

Conduction Block After TAVR: Do I Discharge Early, Monitor, Invasively Investigate, or Pace?

Presenter: David Wood

June 13, 2019

Presentation TVT 2019

New Conduction Abnormalities (Especially LBBB) After TAVR. Do They Matter?

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

Presenter: Josep Rodés-Cabau

June 13, 2019

News Daily News

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Caitlin E. Cox

June 13, 2019

Advertisement

Comparison of 3D Transesophageal Echocardiogram vs. CTA for TAVR Valve Sizing and Resulting Aortic Regurgitation

Diastolic Dysfunction and Clinical Outcomes in Non-Typical Aortic Stenosis Subtypes After Transcatheter Aortic Valve Replacement

Renin-Angiotensin-Aldosterone System Inhibitors Are Associated With Reno-Protective Effects in Aging Patients Undergoing Transcatheter Aortic Valve Replacement

Utilizing a Protocol-Driven vs. a Guideline-Driven Approach for Management of Conduction Abnormalities After Transcatheter Aortic Valve Replacement

Does Orienting Sapien 3 During Crimping in TAVR Affect Final Orientation to Coronaries to Impact TAV-in-TAV and Coronary Reaccess? A Pilot Study

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Technology Description and Clinical Data

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Technology Description, Clinical Data and Plans for the US Pivotal Trial

Which Patients Should Still Have Surgical AVR? Who Are Poor Candidates for TAVR?

What Don’t We Know About TAVR (Coronary Access, Heart Block, Thrombosis, Durability, Repeatability)? Does it Matter?

Comparing the Low-Risk Trials (PARTNER 3 and Medtronic Low-Risk)

Does Surgical Risk Still Matter When Evaluating for TAVR?

The LOTUS Edge TAVR System: Clinical Trial Updates

Design Characteristics, Clinical Data, and Future Vision

Design Characteristics, Clinical Data, and Future Vision

Conduction Block After TAVR: Do I Discharge Early, Monitor, Invasively Investigate, or Pace?

New Conduction Abnormalities (Especially LBBB) After TAVR. Do They Matter?

Pacemakers After TAVR: Patient, Device, Procedural Factors. Do They Matter?

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content